Literature DB >> 7724697

The scientific case that nicotine is addictive.

I P Stolerman1, M J Jarvis.   

Abstract

Despite the wide-ranging and authoritative 1988 review by the US Surgeon General, views questioning the addictiveness of nicotine contine to be expressed in some quarters. This lack of complete consensus is not unexpected, since no universally agreed scientific definition of addiction exists. In this paper we briefly consider a number of lines of evidence from both the human and animal literature bearing on the addictiveness of nicotine. Patterns of use by smokers and the remarkable intractability of the smoking habit point to compulsive use as the norm. Studies in both animal and human subjects have shown that nicotine can function as reinforcer, albeit under a more limited range of conditions than with some other drugs of abuse. In drug discrimination paradigms there is some cross-generalisation between nicotine on the one hand, and amphetamine and cocaine on the other. A well-defined nicotine withdrawal syndrome has been delineated which is alleviated by nicotine replacement. Nicotine replacement also enhances outcomes in smoking cessation, roughly doubling success rates. In total, the evidence clearly identifies nicotine as a powerful drug of addiction, comparable to heroin, cocaine and alcohol.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7724697     DOI: 10.1007/bf02245088

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  70 in total

1.  Smoking cessation among self-quitters.

Authors:  J R Hughes; S B Gulliver; J W Fenwick; W A Valliere; K Cruser; S Pepper; P Shea; L J Solomon; B S Flynn
Journal:  Health Psychol       Date:  1992       Impact factor: 4.267

2.  MK801 attenuates behavioural adaptation to chronic nicotine administration in rats.

Authors:  M Shoaib; I P Stolerman
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

3.  A double-blind trial of a 16-hour transdermal nicotine patch in smoking cessation.

Authors:  P Tønnesen; J Nørregaard; K Simonsen; U Säwe
Journal:  N Engl J Med       Date:  1991-08-01       Impact factor: 91.245

Review 4.  Cocaine addiction: psychology and neurophysiology.

Authors:  F H Gawin
Journal:  Science       Date:  1991-03-29       Impact factor: 47.728

5.  Effect of nicotine on the tobacco withdrawal syndrome.

Authors:  J R Hughes; D K Hatsukami; R W Pickens; D Krahn; S Malin; A Luknic
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

6.  Transdermal nicotine for smoking cessation. Six-month results from two multicenter controlled clinical trials. Transdermal Nicotine Study Group.

Authors: 
Journal:  JAMA       Date:  1991-12-11       Impact factor: 56.272

7.  Qualitative differences in the discriminative stimulus effects of low and high doses of caffeine in the rat.

Authors:  G K Mumford; S G Holtzman
Journal:  J Pharmacol Exp Ther       Date:  1991-09       Impact factor: 4.030

8.  Task-specific effects of nicotine in rats. Intracranial self-stimulation and locomotor activity.

Authors:  G J Schaefer; R P Michael
Journal:  Neuropharmacology       Date:  1986-02       Impact factor: 5.250

9.  Rodent model of nicotine abstinence syndrome.

Authors:  D H Malin; J R Lake; P Newlin-Maultsby; L K Roberts; J G Lanier; V A Carter; J S Cunningham; O B Wilson
Journal:  Pharmacol Biochem Behav       Date:  1992-11       Impact factor: 3.533

10.  Time course study of the effects of chronic nicotine infusion on drug response and brain receptors.

Authors:  M J Marks; J A Stitzel; A C Collins
Journal:  J Pharmacol Exp Ther       Date:  1985-12       Impact factor: 4.030

View more
  235 in total

1.  Direct administration of ifenprodil and citalopram into the nucleus accumbens inhibits cue-induced nicotine seeking and associated glutamatergic plasticity.

Authors:  Jonna M Leyrer-Jackson; Jose A Piña; Joseph McCallum; M Foster Olive; Cassandra D Gipson
Journal:  Brain Struct Funct       Date:  2020-06-26       Impact factor: 3.270

2.  Concurrent access to nicotine and sucrose in rats.

Authors:  Leigh V Panlilio; Lee Hogarth; Mohammed Shoaib
Journal:  Psychopharmacology (Berl)       Date:  2014-11-01       Impact factor: 4.530

3.  Prolonged nicotine dependence associated with extended access to nicotine self-administration in rats.

Authors:  Neil E Paterson; Athina Markou
Journal:  Psychopharmacology (Berl)       Date:  2004-01-08       Impact factor: 4.530

4.  Precipitated withdrawal from nicotine reduces reinforcing effects of a visual stimulus for rats.

Authors:  Matthew T Weaver; Maggie Sweitzer; Sarah Coddington; Jaimee Sheppard; Nicole Verdecchia; Anthony R Caggiula; Alan F Sved; Eric C Donny
Journal:  Nicotine Tob Res       Date:  2012-01-04       Impact factor: 4.244

Review 5.  Tobacco addiction and the dysregulation of brain stress systems.

Authors:  Adrie W Bruijnzeel
Journal:  Neurosci Biobehav Rev       Date:  2012-03-03       Impact factor: 8.989

Review 6.  From smoking to lung cancer: the CHRNA5/A3/B4 connection.

Authors:  M R D Improgo; M D Scofield; A R Tapper; P D Gardner
Journal:  Oncogene       Date:  2010-06-28       Impact factor: 9.867

7.  A Control Theory Model of Smoking.

Authors:  Georgiy Bobashev; John Holloway; Eric Solano; Boris Gutkin
Journal:  Methods Rep RTI Press       Date:  2017-06

8.  Patterns of intermittent smoking: An analysis using Ecological Momentary Assessment.

Authors:  Saul Shiffman; Thomas R Kirchner; Stuart G Ferguson; Deborah M Scharf
Journal:  Addict Behav       Date:  2009-01-31       Impact factor: 3.913

Review 9.  The nicotine inhaler: clinical pharmacokinetics and comparison with other nicotine treatments.

Authors:  N G Schneider; R E Olmstead; M A Franzon; E Lunell
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

10.  Attenuation by baclofen of nicotine rewarding properties and nicotine withdrawal manifestations.

Authors:  Andrés P Varani; Ester Aso; Lirane Machado Moutinho; Rafael Maldonado; Graciela N Balerio
Journal:  Psychopharmacology (Berl)       Date:  2014-02-20       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.